Showing Results for: “diabetes exercise”

American Diabetes Association Symposium Demonstrates Benefits of Once Weekly Drug for Weight Loss and Glycemic Control Today, findings from SURMOUNT-2, a study of tirzepatide in participants with type 2 diabetes who have obesity were announced, demonstrating more weight loss in individuals with diabetes than any other medication to date. The results were presented at the 83rd Scientific Sessions of the American Diabetes Association ® (ADA) in San Diego, CA and were simultaneously published in The Lancet . Obesity impacts 650 million people worldwide including nearly half of all Americans and

First-of-Its-Kind Study Compares Open-Source Automated Insulin Delivery to Sensor-Augmented Pump Therapy Results from the CREATE Trial demonstrated open-source automated insulin delivery (AID) systems are a safe and effective therapy for people with type 1 diabetes. Findings from the randomized controlled trial (RCT) comparing open-source AID to sensor-augmented pump therapy (SAPT) were presented today at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA). Open-source AID systems were developed to reduce the burden of living with diabetes by combining an insulin pump

The American Diabetes Association® (ADA) applauds Alabama Governor Kay Ivey today for signing House Bill 249, legislation that will cap insulin co-sharing at $100 per month for those on state-regulated health plans, without regard to the policy deductible, and regardless of the quantity or type of insulin needed to fill the insured patient's prescription. Bill sponsor, Representative Paul Lee, Chairman of the House Health Committee and Senator Tom Butler, Chairman of the Senate Veteran’s and Military Affairs Committee provided leadership on this important legislation to reduce the burden of

Today, the American Diabetes Association® (ADA) applauded Kentucky Governor Andy Beshear for signing legislation that will cap insulin co-pays at $30 per month, regardless of the quantity or type of insulin needed to fill the insured patient's prescription. Governor Beshear and bill sponsor Representative Danny Bentley provided expert leadership on this important legislation to reduce the burden of insulin costs for people living with diabetes. Kentucky joins 14 other states as well as the District of Columbia that have enacted insulin copay caps to reduce costs of this life-saving drug.

The Teplizumab Prevention Trial has given validity to the concept that immune therapy can delay the diagnosis of type 1 diabetes (T1D), according to findings presented at a symposium entitled “New Therapeutic Approaches and Insights for Type 1 Diabetes” today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. Family members of someone with T1D have a 15 times greater risk of developing T1D than individuals from the general population. Testing can determine the presence of autoantibodies, indicating risk for T1D, and the

On May 22, 2019, Colorado Governor Jared Polis signed the first bill in the nation that will cap insulin co-pays at $100 per month, regardless of the number of vials needed. House Bill 1216: Reduce Insulin Prices, also enlists the Colorado Attorney General to investigate the rising price of insulin in Colorado and make recommendations to the General Assembly for further action. The American Diabetes Association (ADA) applauds Governor Polis and bill sponsors, Representative Dylan Roberts and Senators Kerry Donovan and Kevin Priola, for their leadership on this important legislation to reduce

The American Diabetes Association® (ADA) will present the 2019 Outstanding Scientific Achievement Award (OSAA) to Sadaf Farooqi, MB, ChB (Hons), PhD. Dr. Farooqi will be recognized with this honor, which is given annually for research in diabetes that demonstrates particular independence of thought and originality, during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. She will deliver her OSAA Lecture, titled “ Obesity and the Biology of Weight Regulation ,” during the National Scientific and Health Care Achievement Awards Presentation

Initial data indicate that children presented with higher acuity compared to the previous year New data show that the incidence and acuity of type 2 diabetes in children increased significantly during the peak of the COVID-19 pandemic, with more pediatric patients hospitalized from March to December 2020 compared to the same time period in 2019. Findings from the retrospective chart review were presented as a late-breaking poster session at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Stay-at-home orders due to the COVID-19 pandemic exacerbated risk

Texas becomes 19th state to sign vital legislation to help insulin costs for those with diabetes Today, the American Diabetes Association ® (ADA) applauded a major victory secured for people with diabetes in Texas as Governor Greg Abbott signed legislation yesterday that will help make insulin more affordable for Texans on state-regulated health plans. The new law, created by Senate Bill 827 and supported by the ADA, limits cost-sharing to $25 per prescription for a 30-day supply of insulin, regardless of the amount or type of insulin needed. With the signing of this bill, Texas becomes the

Reduced hospitalization rates among people with low self-monitoring of blood glucose (SMBG) are especially pronounced People using Abbott’s FreeStyle Libre, a sensor-based glucose monitoring system, experienced a considerable decrease in ketoacidosis-related hospitalizations—52% for type 1 diabetes and 47% for type 2 diabetes—according to the study titled “Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in Type 1 and Type 2 Diabetes in France, Especially in People with Low Self-Monitoring of Blood Glucose (SMBG): A Nationwide Study,” presented today at the American